Explanation of the manufacturer of the news-making drug “Losartan”

Author:
Actoverco
Date:
08 July 2019
8

Following the Food and Drug Administration's order to collect Losartan drug with Indian active ingredient from the supply level, the Iranian company "Actoverco" announced in a statement that it has issued an immediate stop order to sell Losartan drug to distribution companies and the drug collection process from the pharmacies has started.

Following the Food and Drug Administration’s order to collect Losartan drug with Indian active ingredient from the supply level, the Iranian company “Actoverco” announced in a statement that it has issued an immediate stop order to sell Losartan drug to distribution companies and the drug collection process from the pharmacies has started.

According to the public relations of Actoverco Group, following the correspondence of the Food and Drug Administration on July 2, 2019 regarding the recall (collection) of Losartan drug of Actoverco  company, unfortunately, unrealistic and baseless themes were published by a few media, which by exaggerating and spreading lies about Losartan drug and creating concern and anxiety in the public mind, have posed a series of accusations and untrue information about Actoverc company with a history of 50 years.

Actoverco factory is currently one of the top drug manufacturers in the Middle East, which succeeds in producing all types of drugs with highest quality by observance of patient rights and constant commitment to it, obtaining GMP certification (optimal production standard) for all production lines as well as international standards observance. In order to enlighten the public opinion and address the rightful concerns of the people and the pharmaceutical and medical community of the country regarding the drug Losartan, the Actoverc group provides the following explanations to the public:

  1. As soon as Actoverco group received the recall correspondence from the Food and Drug Administration, has ordered the immediate cessation of Losartan’s sale to distribution companies, and the process of collecting the drug from the pharmacies has begun.
  2. Drug recall is a common occurrence in the pharmaceutical industry that occurs due to various factors, so that since the beginning of 2017, FDA (American Food and Drug Administration) recalled about 1000 cases of drug and food products and this issue is precedential in our country, too. Given that all these cases are carried out by the order of the Food and Drug Administration and through legal channels, it is questionable and unfortunate why this time and unlike previous cases, drug recall has caused so much concern and anxiety in the public minds?!
  3. Hetero company, with more than 36 drug factories in different parts of the world (including the United States), is one of the largest and most reputable companies producing raw materials and final pharmaceutical products in the world, which exports its products to more than 126 countries around the globe. Additionally and more importantly, the major pharmaceutical manufacturers of our own country, provide raw materials of some of their drugs from Hetero Company.

At the end Actoverco company announces that it will take the necessary measures in accordance to its legal, ethical and professional duties and immediately after being informed of the Food and Drug Administration’s order; moreover, complete coordination process with Food and Drug Administration in all produced products has been considered till now and will be consider in future.

Reference: ISNA

Related Posts

actover news-min

Actoverco launches diabetes drug “Trytis”

labour day

“International Labour Day”

فوتسال-min

Actoverco host a Futsal tournament!

a letter from nahaleh naraghi

Bright future for pharmaceutical industry in Iran!

national health week actoverco

Message from Ms. Nahaleh Naraqi on the occasion of Health Week